Because
of the lack of resources on some developing countries, most people resort to generic
medicines which cost less than branded drugs. Moreover, many third world
nations have no capacities and capabilities for pharmaceutical manufacturing
which forces even authorities to allow generic copies of medicines to penetrate
the market. Generic competition is one of the driving factors on the cost and
quality reduction in many countries.
As
defined by the
Peterson Group, non-profit organization campaigning against
proliferation of counterfeit medicines, generic medicines are pharmaceutical
copies of drugs which are manufactured without license from the innovator
companies and marketed after the expiry date of the patented or other exclusive
rights. It is public obligation that the government provides affordable and
legitimate medicine functions, however, with the incapability to find good
resources, many governments fail in this respect.
Generic
medicines are not entirely fraudulent per se but are mostly
substandard. Nonetheless, the threat can
still be bona fide with what many health professions fear of: circumvention of
health regulation, undercutting public confidence, and potentially providing a
comparatively easy source of income to criminal elements.
Firstly,
health regulations are mostly underrated on generic pharmacies starting from
the fact that issuance of prescription are often ignored and neglected. Added
to this fact is that generic pharmacies often employ unlicensed pharmacists who
do not have enough knowledge on medical terminologies and lexicons.
The
second main concern of authorities is that generic pharmacies may undercut
public confidence. Faith and trust placed on medicine for safety and proper
health treatment implementation is put into question. Even branded medicines
being sold in generic pharmacies are doubted to be substandard.
Furthermore,
patronization to legitimate medicines has dropped dramatically in the recent
years. According
to reviews, the cost and effectiveness of genuine medicines are
discarded as mere marketing stance by most pharmaceutical companies as
loyalties shift to generics which cost less and promise the same effects.
Lastly,
generic medicines pave an easier way for criminal counterfeiting.
Recent
seizures of drug shipments in one of the hidden ports in outer Jakarta area in Indonesia
have sparked concern that efforts to control counterfeits are a smokescreen to
curb the sale of generics in the archipelago. Officials claimed generic drugs
were counterfeit, placing efforts to adopt and enforce anti-counterfeit
legislation in domestic laws as well as in bilateral and multilateral agreements
into jeopardy.
No comments:
Post a Comment